Recently, several two-component FAD-dependent monooxygenases have been reported (5, 23, 35) ; however, the function of each component in catalysis is unknown. In our recent study we have found that the FMN reductase that supplies FMNH 2 to nitrilotriacetate monooxygenase has significant sequence similarities to the small component (HpaC) of a two-component monooxygenase, 4-hydroxyphenylacetate 3-hydroxylase (HpaB and HpaC) of Escherichia coli strain W (34). It has been suggested that HpaC is a coupling factor that enhances NADH oxidation for HpaB (23). Because HpaB and HpaC together catalyze the oxidation of 4-hydroxyphenylacetate in the presence of NADH and FAD, we hypothesized that HpaC was a flavin reductase that could reduce FAD to FADH 2 and that HpaB was an FADH 2 -utilizing monooxygenase. We present here the characterization of HpaB as a new type of FADH 2 -utilizing monooxygenase. The large components of several other two-component FAD-dependent monooxygenases have both catalytic and sequence similarities to HpaB and may also be FADH 2 -utilizing monooxygenases.
Two major groups of flavin-dependent monooxygenases have been reported. The first group usually consists of enzymes of single polypeptides that have either flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) as their prosthetic group and use either NADH or NADPH as their cosubstrate (8, 30) . The second group utilizes reduced FMN (FMNH 2 ) as a cosubstrate rather than a prosthetic group and requires a separate FMN reductase to supply FMNH 2 . Bacterial luciferase of Photobacterium fischeri is the first reported FMNH 2 -utilizing monooxygenase (32) . Recently, pristinamycin II A synthase of Streptomyces pristinaespiralis (24) , nitrilotriacetate monooxygenase of Chelatobacter heintzii (34) , EDTA monooxygenases of two EDTA-degrading bacteria (22, 33) , and two monooxygenases involved in desulfurization from Rhodococcus sp. strain IGTS8 (12, 19) have been characterized and shown to be FMNH 2 -utilizing monooxygenases. These FMNH 2 -utilizing monooxygenases appear to attack carbonnitrogen bonds, carbon-sulfur bonds, carbon-carbon double bonds, or aldehyde groups of nonaromatic compounds. FMNH 2 is supplied by FMN reductases with NADH as a reductant.
Recently, several two-component FAD-dependent monooxygenases have been reported (5, 23, 35) ; however, the function of each component in catalysis is unknown. In our recent study we have found that the FMN reductase that supplies FMNH 2 to nitrilotriacetate monooxygenase has significant sequence similarities to the small component (HpaC) of a two-component monooxygenase, 4-hydroxyphenylacetate 3-hydroxylase (HpaB and HpaC) of Escherichia coli strain W (34) . It has been suggested that HpaC is a coupling factor that enhances NADH oxidation for HpaB (23) . Because HpaB and HpaC together catalyze the oxidation of 4-hydroxyphenylacetate in the presence of NADH and FAD, we hypothesized that HpaC was a flavin reductase that could reduce FAD to FADH 2 and that HpaB was an FADH 2 -utilizing monooxygenase. We present here the characterization of HpaB as a new type of FADH 2 -utilizing monooxygenase. The large components of several other two-component FAD-dependent monooxygenases have both catalytic and sequence similarities to HpaB and may also be FADH 2 -utilizing monooxygenases.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. E. coli NovaBlue was used for pET-30 LIC cloning, and strain BL21(DE3) was used for gene expression (Novagen, Madison, Wis.). E. coli strains were routinely grown at 37°C in LuriaBertani (LB) medium or on LB agar (26) , except for strain BL21(DE3) that was incubated at room temperature when used to produce functional enzymes. Kanamycin (Sigma, St. Louis, Mo.) was used at 30 g per ml in culture media.
Gene cloning and expression. To overproduce NAD(P)H:flavin oxidoreductase (Fre) (27) in E. coli, PCR primers were designed to clone fre into pET-30 LIC vector (Novagen). The forward primer (Fre5, 5Ј-ACA-GAG-AAA-GCA-T AT-GAC-AAC-CTT-3Ј) was at base positions of 1439 to 1462 of gene fre (GenBank M61182) (27) , in which an NdeI site (underlined) was introduced by altering two bases. The reverse primer (Fre3, 5Ј-AAA-TGC-CAC-TGA-ATT-C CA-GTT-TAG-3Ј) was located at positions 2196 to 2219 with an introduced EcoRI site. The gene was amplified with the primers and genomic DNA from E. coli DH5␣ for 25 cycles of PCR with a thermal profile of 30 s at 94°C, 30 s at 55°C, and 1 min at 72°C. The amplification yielded a DNA product of 781 bp. The PCR product was cut by NdeI and EcoRI and then ligated into the plasmid pET30-LIC (Novagen) that was previously digested by NdeI and EcoRI to produce plasmid pES1. For overproduction of HpaB, the forward primer (HpaB5, 5Ј-GTA-GAG-GTC-CAT-ATG-AAA-CCA-GAA-3Ј) was from base positions 1100 to 1123 (GenBank Z29081) (24) with an introduced NdeI site, and the reverse primer (HpaB3, 5Ј-TGC-ATC-TTA-AGC-TTC-TGC-TGC-GTT-3Ј) was from base positions 2696 to 2673 with an introduced HindIII site. The gene was amplified by PCR with plasmid pAJ224 (24) DNA as template and cloned into pET-30 LIC vector to produce pES2. Plasmids pES1 and pES2 were transformed into E. coli NovaBlue for plasmid identification and recovery. The recovered plasmids were later transformed into E. coli BL21(DE3) for protein production upon IPTG (isopropyl-␤-D-thiogalactopyranoside) induction (Novagen).
Protein purification. Protein Fre was purified according to a previously reported method (9) . Because the protein was overproduced, not all of the steps reported before were needed to purify it to homogeneity. BL21(DE3) cells (0.4 g [wet weight]) carrying pES1 harvested from 200 ml of culture were suspended in 10 ml of 20 mM potassium phosphate (KPi) buffer (pH 7.0) with 2 mM EDTA. The cell suspension was passed through a French pressure cell once at 18,000 lb/in 2 . The sample was centrifuged at 18,000 ϫ g for 15 min to remove cell debris. Solid ammonium sulfate was added to the supernatant to bring it to 70% saturation. The precipitate was sedimented by centrifugation, resuspended in 1 ml of 20 mM KPi buffer (pH 7.0), and dialyzed overnight in the same buffer. The dialyzed sample was injected onto a Bioscale Q column (7 by 52 mm; Bio-Rad, Hercules, Calif.), and proteins were eluted with a 20-ml gradient of 0 to 400 mM NaCl in 20 mM KPi buffer (pH 7.0). Fre was eluted off the column around 200 mM NaCl as a major peak. Fre was collected, concentrated to less than 0.8 ml, and injected onto a Superdex 75 column (10 by 300 mm; Pharmacia, Alameda, Calif.). Fre was eluted with the 20 mM KPi buffer containing 150 mM NaCl. Protein HpaB was purified by using a slightly modified procedure from that previously reported (24) . E. coli cells (2.5 g) producing HpaB were harvested from 1-liter cultures, suspended in 20 ml of 20 mM KPi buffer (pH 7.0) with 2 mM EDTA and 1 mM dithiothreitol (DTT), and broken by passage through a French press cell three times at 1,800 lb/in 2 . The cell lysate was then centrifuged at 18,000 ϫ g for 15 min to remove cell debris. Solid ammonium sulfate was added to the supernatant to 20% saturation with constant mixing. The sample was then centrifuged as described above to remove precipitated proteins. The supernatant containing less than 130 mg of protein was loaded onto a phenyl agarose column (16 by 120 mm) and eluted with 100 ml of a linear gradient of ammonium sulfate (20 to 0% saturation) in the 20 mM KPi buffer. When the gradient finished, HpaB was eluted off the column by another 40 ml of the 20 mM KPi buffer. HpaB was concentrated to about 2 ml, and trace amounts of ammonium sulfate was removed by dialysis in the KPi buffer with 1 mM DTT for several hours. The sample was injected onto a 2-ml Bioscale Q column and eluted with a 20-ml gradient of NaCl from 0 to 200 mM in the KPi buffer with 1 mM DTT. HpaB was eluted off the column around 100 mM NaCl.
Enzyme assays. 4-Hydroxyphenylacetate 3-hydroxylase activity was measured by analysis of the conversion of 4-hydroxyphenylacetate to 3,4-dihydroxyphenylacetate with a high-pressure liquid chromatography (HPLC) method as previously reported (18) . The reaction was normally performed with 20 mM KPi buffer (pH 7.0) containing 10 M FAD, 1 mM 4-hydroxyphenylacetate, 2 mM NADH, 90 U of catalase (Sigma) per ml, and various amounts of Fre and HpaB at 24°C. One unit was defined as the amount of HpaB required to catalyze the consumption of 1 nmol of 4-hydroxyphenylacetate per min when HpaB was the limiting factor in the assays. Flavin reductase activity was determined by monitoring the consumption of NADH in 20 mM KPi buffer (pH 7.0) containing 200 M NADH and 10 M FAD or FMN at 24°C. One unit of Fre was defined as the amount required to catalyze the consumption of 1 nmol of NADH per min (9) . FAD concentration changes during FAD reduction were monitored at 450 nm. The 4-hydroxyphenylacetate 3-hydroxylase activity of HpaB was also tested with chemically produced FADH 2 by using a reaction mixture containing 1 mM 4-hydroxyphenylacetate, 10 M HpaB, and 100 M FAD in 20 mM KPi buffer (pH 7.0). The mixture was transferred into an anaerobic chamber, and FAD was reduced to FADH 2 with 3 mM titanium citrate (36) . The mixture was then removed from the anaerobic chamber, and O 2 from air was permitted to diffuse into the reaction mixture to complete the reaction. After 30 min, the amount of 3,4-dihydroxyphenylacetate produced was analyzed by HPLC.
Analytical methods. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was done by the method of Laemmli (17) . Gels were stained for proteins with GelCode Blue (Pierce, Rockford, Ill.). Protein concentrations were determined with a protein dye reagent (6) with bovine serum albumin as the standard.
Oxygen consumption. Oxygen consumption was determined in a closed reaction vessel (0.6 ml, total volume) fitted with a Clark-type oxygen electrode (Instech, Plymouth Meeting, Pa.). The electrode was calibrated with a chemical method by using N-methylphynazonium methosulfate and NADH to quantitatively consume O 2 (25) . Two sets of experiments were carried out with 10 M FAD in the reaction mixture. The first set contained 53 U of Fre only. The second set contained 53 U of Fre and 10 M HpaB. In both cases, NADH was added in a 2.5-l volume to a final concentration of 84 M to initiate O 2 consumption. When O 2 consumption stopped, 90 U of catalase (Sigma) was added to release O 2 from H 2 O 2 . After the reactions were completed, the 3,4-dihydroxyphenylacetate produced was quantified by HPLC.
RESULTS
Protein production. For ease of purification, the genes fre and hpaB were cloned into the pET-30 LIC vector to yield plasmids pES1 and pES2, respectively. Strain BL21(DE3) carrying pES1 or pES2 produced large quantities of soluble and active Fre or HpaB when growing at room temperature (Fig.  1) . When growing at 37°C, the cells produced these proteins mainly in inclusion bodies. Neither Fre nor HpaB were fusion proteins. They were both purified to apparent homogeneity (Fig. 1) . For a typical purification, 2.6 mg of Fre was purified from 27 mg of total protein in the cell extract with a 32% recovery of Fre activity, and 22 mg of HpaB was purified from 130 mg of the cell extract with a 55% recovery of HpaB activity. (Fig. 2) . HPLC analysis showed the production of 46 Ϯ 2 (standard deviation of three samples) nmol of 3,4-dihydroxyphenylacetate. When HpaB alone was added to the reaction mixture, there was no consumption of NADH, 4-hydroxyphenylacetate, or O 2 . In contrast, Fre alone led to the quantitative consumption of 50 nmol of NADH and 50 nmol of O 2 without the oxidation of 4-hydroxyphenylacetate (Fig. 2) . In this case, O 2 was converted to H 2 O 2 , from which 25 Ϯ 1 (standard deviation of three samples) nmol of O 2 was released by catalase (Fig. 2) . Therefore, in the presence of both proteins FADH 2 generated by Fre was mainly oxidized by HpaB for the conversion of 4-hydroxyphenylacetate to 3,4-dihydroxyphenylacetate, whereas with Fre alone FAD was reduced to FADH 2 and then autoxidized by O 2 to generate H 2 O 2 . Since the oxygen consumption rates were almost the same in the presence or the absence of HpaB (Fig. 2) , it is likely that the reduction of FAD was rate limiting; that is, FADH 2 oxidation by either HpaB or free O 2 was much faster than FAD reduction. HpaB also used chemically produced FADH 2 for 4-hydroxyphenylacetate oxidation. In a mixture containing 100 nmol of chemically reduced FADH 2 with an excess of titanium citrate, 128 nmol of 3,4-dihydroxyphenylacetate was produced. Since the oxidized FAD could be continuously reduced by titanium until all of the reducing agent was consumed, more than 100 nmol of end product was formed. Due to the extreme reactivity of both FADH 2 and titanium with O 2 , it is difficult to quantitatively supply chemically produced FADH 2 to HpaB for 4-hydroxyphenylacetate oxidation. Controls without HpaB or FAD did not produce 3,4-dihydroxyphenylacetate.
FAD reduction and FADH 2 oxidation. When the concentration of FAD was followed at 450 nm during FAD reduction in 1 ml of reaction mixture by 176 U of Fre, FAD (9.6 M) and FADH 2 (0.40 Ϯ 0.05 M) (standard deviation of three samples) concentrations were found to remain in a constant ratio until NADH was almost completely consumed at about 100 s (Fig. 3, curve 1) . The lack of FADH 2 accumulation during FAD reduction again indicates rapid autoxidation of FADH 2 . When HpaB was also added to the reaction mixture without 4-hydroxyphenylacetate, the concentration of FADH 2 increased proportionally to the amount of HpaB added (Fig. 3,  curves 2 and 3) . With 5 M HpaB, 3.1 Ϯ 0.3 M FADH 2 (standard deviation of three samples) was stable for about 80 s. FADH 2 was slowly oxidized at a maximal rate of 0.053 M per s after most of the NADH was consumed (Fig. 3, curve 2 ). Since FADH 2 was rapidly autoxidized by O 2 , the increased FADH 2 should be due to the presence of HpaB, which bound and protected FADH 2 from rapid oxidation by O 2 . When 10 M HpaB was added, 6.3 Ϯ 0.6 M FADH 2 (standard deviation of three samples) was detected and remained at that level for about 80 s. After most of the NADH was consumed, FADH 2 was oxidized relatively slowly at a maximal rate of 0.088 M per second (Fig. 3, curve 3) . Even in the presence of 5 and 10 M HpaB, FAD reduction as measured by NADH consumption remained the same as with Fre alone since the remaining FAD concentrations were still much higher than Fre's K m for FAD (0.8 M) (9) . When the NADH was completely consumed (by approximately 100 s), all FADH 2 was slowly oxidized to FAD.
Coupling the activities of HpaB and Fre. When 4-hydroxyphenylacetate, a substrate of HpaB, was also included in the reaction mixture, only 0.24 Ϯ 0.06 M FADH 2 (standard deviation of three samples) was detected in the initial 30 s (Fig.  3, curve 4) . In this case, the coupling decreased as the final production of 3,4-dihydroxyphenylacetate decreased (Fig. 4) . This uncoupling was alleviated by reducing the amount of FAD in the reaction mixture. When FAD concentrations were around Fre's K m (0.8 M), the final production of 3,4-dihydroxyphenylacetate clearly increased (Fig. 5) . The uncoupling was also alleviated by reducing the amount of Fre instead of FAD in the reaction mixture (data not shown). Since autoxidation of FADH 2 by O 2 to H 2 O 2 is well documented (11, 13) and was also demonstrated in Fig. 2 , the H 2 O 2 produced was not measured in these experiments. Fre also reduces riboflavin and FMN at the expense of NADH (9), but HpaB did not use the reduced riboflavin nor FMNH 2 for 4-hydroxyphenylacetate oxidation. The reduced riboflavin and FMNH 2 were immediately autoxidized by O 2 . In addition, HpaB did not protect FMNH 2 and reduced riboflavin from rapid autoxidation by O 2 .
DISCUSSION
Functional analysis demonstrated that HpaB is an FADH 2 -utilizing monooxygenase that catalyzes the reaction as shown in Fig. 6 . Our results show that only HpaB is responsible for 4-hydroxyphenylacetate oxidation. Since HpaB used either chemically generated FADH 2 or enzymatically generated FADH 2 for 4-hydroxyphenylacetate oxidation, HpaC was not required for the function of HpaB. A continuous supply of FADH 2 was easily achieved by Fre reduction of FAD with NADH as a reductant. Fre has no apparent sequence similarities to HpaC. Fre reduces FAD, FMN, and riboflavin at the expense of NADH in the presence or absence of HpaB. Only FADH 2 was used by HpaB because FAD could not be substituted by either FMN or riboflavin in the reaction mixture containing Fre. HpaC was not characterized in this report, but a recently reported NADPH:FAD oxidoreductase that supplies FMNH 2 to an FMNH 2 -utilizing monooxygenase from Streptomyces viridifaciens (21) has significant sequence homology with HpaC and uses either NADPH or NADH to reduce either FAD or FMN. HpaC may possess similar catalytic properties.
Although FADH 2 is rapidly autoxidized by O 2 , HpaB competed effectively with O 2 to use FADH 2 for 4-hydroxyphenylacetate oxidation. In the absence of HpaB, FADH 2 was quantitatively autoxidized to H 2 O 2 (Fig. 2) . In contrast, under the conditions of Fig. 2 (Fig. 3, curve 4 ) than during FADH 2 autoxidation (Fig. 3, curve 1) . When HpaB concentrations were low, only a small fraction of FADH 2 was used by HpaB for the oxidation of 4-hydroxyphenylacetate and a significant amount of FADH 2 was autoxidized (Fig. 4 and 5) . In the extreme case without HpaB, all FADH 2 was autoxidized to H 2 O 2 ( Fig. 2) (11, 13) . However, lowering the FAD concentration in the reaction mixture can slow down FAD reduction and increase the FADH 2 utilization by HpaB (Fig. 5) . If the coupling of the activities of an FAD reductase and an (Fig. 2) . These data indicate that FADH 2 oxidation by free O 2 is faster than FAD reduction and HpaB can compete with free O 2 for FADH 2 utilization. Figure 3 also provides evidence that HpaB binds FADH 2 . In the absence of 4-hydroxyphenylacetate, HpaB bound FADH 2 and protected it from rapid autoxidation by O 2 . This protection was proportional to the amount of HpaB in the reaction mixture and was only transitory (Fig. 3) (20) . The second difference is the substrates. All the FMNH 2 -utilizing monooxygenases reported so far oxidize nonaromatic compounds (19, 22, (31) (32) (33) (34) , while the FADH 2 -utilizing monooxygenase reported here hydroxylates aromatic compounds. Structurally, HpaB does not have any apparent sequence similarities to any FMNH 2 -utilizing monooxygenases.
HpaB shows high homology with TftD (the large component of chlorophenol 4-monooxygenase) from Burkholderia cepacia AC1100, HadA (the large component of chlorophenol-4-hydroxylase) from B. pickettii DTP0602, and HpaA (the large component of 4-hydroxyphenylacetate 3-hydroxylase) from Klebsiella pneumoniae (14) . On the basis of sequence similarity and the two component nature of these enzymes (10, 14, 29, 35) , TftD (14, 35) , HadA (29) , and HpaA (10) may also belong to FADH 2 -utilizing monooxygenases that all use aromatic compounds as their substrates. We have recently demonstrated that TftD used FADH 2 generated by Fre for the oxidation of chlorophenols (data not shown). Interestingly, there is a wellcharacterized two component 4-hydroxyphenylacetate 3-hydroxylase with the small component containing FAD and the large component serving as a coupling factor for 4-hydroxyphenylacetate oxidation (2, 3, 4) . It seems that the large component of this enzyme is different from HpaC because it is only 38 kDa (2), whereas HpaC is about 58 kDa (23) .
A BLAST search (1) with the amino acid sequence of HpaB revealed that HpaB also has sequence similarities to seven other proteins. These seven proteins include a phenol hydroxylase (PheA) that oxidizes phenol to catechol from Bacillus thermoleovorans (7). This is not surprising since HpaB also oxidizes phenol to catechol (23) . Another protein is PvcC, whose gene is part of a gene cluster involved in siderophore pyoverdine biosynthesis but whose function has not been reported (28) . PvcC may catalyze the oxidation of L-tyrosine to L-dopa, the first step in the biosynthesis pathway, because both HpaB (18) and HpaA (10) can oxidize L-tyrosine to L-dopa. All the other five proteins are deduced from genome projects on the basis of sequence similarities to HpaB, one from Photorhabdus luminescens (GenBank AF021838), one from Bacillus subtilis (16) , and three from Archaeoglobus fulgidus (15) . It is unclear why a strict anaerobic archaeon A. fulgidus has genes encoding three monooxygenases. If all these enzymes are FADH 2 -utilizing monooxygenases, they are a new class of enzymes widespread in the microbial world involved in both biodegradation and biosynthesis.
